Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.92152 | 65 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.87636 | 65 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.90626 | 65 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.74318 | 63 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.82085 | 64 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.07889 | 67 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.06652 | 66 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.89244 | 65 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.81768 | 64 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.663 | 62 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.89263 | 65 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.84431 | 64 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.93862 | 65 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.2709 | 69 |